Surgery CME

Credits: 1.00 CME / MOC / CE
Medical Learning Institute, Inc.
The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care
Naiyer Rizvi, MD
14 December, 2018
Credits: 1.50 CME
Penn State College of Medicine
Innovative Therapy in B-Cell Malignancies: An Expert Tumor Board on Novel Agent Classes in CLL, FL, and MCL
Nathan Fowler, MD
9 October, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Tracing the Arc of Immunotherapy in Melanoma: Insights on the Current Role and Cutting-Edge Uses of Checkpoint Inhibitors for Patient Care
Omid Hamid, MD
11 July, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
Making the TRK to Precision Medicine in Cancer: The Promise of Targeting TRK Fusions in Lung, Breast, GI, and Other Tumors
George Demetri, MD
9 July, 2018
Credits: 1.00 CME
The Medical College of Wisconsin
New Thinking on GVHD Management in HSCT Recipients: Focus on Underlying Immunology and Innovative Therapeutics
David Miklos, MD, PhD
11 April, 2018
Credits: 1.00 CME
The Medical College of Wisconsin
Refining the Management of CMV in HCT Recipients: What Does the Future Hold?
Francisco Marty, MD
5 April, 2018
Credits: 1.00 CME
The Medical College of Wisconsin
Realizing the Promise of CAR-T Cell Therapy for Leukemia and Lymphoma: Implications for Long-Term Care in the Era of Stem Cell Transplantation
Stephan Grupp, MD, PhD
5 April, 2018
Credits: 1.00 CME
The Medical College of Wisconsin
Novel Induction Options in AML: Assessing the Implications for HCT-Eligible Patients
Jorge Cortes, MD
4 April, 2018
Credits: 1.00 CME
The Medical College of Wisconsin
Treatment Innovation in Hodgkin Lymphoma: Integrating New Therapeutic Options With Autologous Transplant Across Clinical Settings
Anas Younes, MD
4 April, 2018